DWTX - Dogwood Therapeutics, Inc.

https://dwtx.com

Momentum: Bearish

Recent News

No recent news found.

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

Dogwood Therapeutics, Inc., a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company is headquartered in Alpharetta, Georgia.

52W High

$21.78

52W Low

$1.62

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

1.81

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

0.22

EV/Revenue (<3 favorable)

N/A

P/S (TTM) (<3 favorable)

N/A

P/B (<3 favorable)

1.35

Ownership

Retail‑heavy

Source: Overview

Insiders (1–5% typical)

13.07%

Institutions (25–75% balanced)

5.92%

Shares Outstanding

1,911,100

Float

1,624,900

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

Gross Profit (TTM)

EPS (TTM)

-19.25

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

N/A

ROE (TTM) (>15% strong)

-0.58%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

N/A

Momentum

Bearish momentum

Value

0.0021

0.0020

Trend

Rising

Signal Cross

No cross

As of

Sep. 12, 2025